vs

Side-by-side financial comparison of BLACKBAUD INC (BLKB) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

BLACKBAUD INC is the larger business by last-quarter revenue ($281.1M vs $270.8M, roughly 1.0× HUTCHMED (China) Ltd). BLACKBAUD INC runs the higher net margin — 11.1% vs 0.7%, a 10.4% gap on every dollar of revenue. On growth, BLACKBAUD INC posted the faster year-over-year revenue change (4.2% vs -16.5%). BLACKBAUD INC produced more free cash flow last quarter ($37.0M vs $3.4M).

Blackbaud, Inc. is a cloud computing provider that supports nonprofits, foundations, corporations, education institutions, healthcare organizations, religious organizations, and individual change agents. Its products focus on fundraising, website management, CRM, analytics, financial management, ticketing, and education administration.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

BLKB vs HCM — Head-to-Head

Bigger by revenue
BLKB
BLKB
1.0× larger
BLKB
$281.1M
$270.8M
HCM
Growing faster (revenue YoY)
BLKB
BLKB
+20.7% gap
BLKB
4.2%
-16.5%
HCM
Higher net margin
BLKB
BLKB
10.4% more per $
BLKB
11.1%
0.7%
HCM
More free cash flow
BLKB
BLKB
$33.6M more FCF
BLKB
$37.0M
$3.4M
HCM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BLKB
BLKB
HCM
HCM
Revenue
$281.1M
$270.8M
Net Profit
$31.1M
$2.0M
Gross Margin
59.2%
37.7%
Operating Margin
18.3%
-13.2%
Net Margin
11.1%
0.7%
Revenue YoY
4.2%
-16.5%
Net Profit YoY
620.3%
-83.6%
EPS (diluted)
$0.67
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLKB
BLKB
HCM
HCM
Q1 26
$281.1M
Q4 25
$295.3M
$270.8M
Q3 25
$281.1M
Q2 25
$282.0M
$277.7M
Q1 25
$269.9M
$324.5M
Q4 24
$302.1M
Q3 24
$286.6M
Q2 24
$287.3M
$305.7M
Net Profit
BLKB
BLKB
HCM
HCM
Q1 26
$31.1M
Q4 25
$36.7M
$2.0M
Q3 25
$47.5M
Q2 25
$26.5M
$455.0M
Q1 25
$4.3M
$11.9M
Q4 24
$-346.4M
Q3 24
$18.3M
Q2 24
$21.2M
$25.8M
Gross Margin
BLKB
BLKB
HCM
HCM
Q1 26
59.2%
Q4 25
58.3%
37.7%
Q3 25
59.6%
Q2 25
59.7%
0.1%
Q1 25
57.5%
48.0%
Q4 24
53.8%
Q3 24
54.9%
Q2 24
56.0%
41.1%
Operating Margin
BLKB
BLKB
HCM
HCM
Q1 26
18.3%
Q4 25
20.0%
-13.2%
Q3 25
19.4%
Q2 25
20.3%
-1.3%
Q1 25
7.3%
-5.0%
Q4 24
-121.5%
Q3 24
14.4%
Q2 24
14.4%
-9.0%
Net Margin
BLKB
BLKB
HCM
HCM
Q1 26
11.1%
Q4 25
12.4%
0.7%
Q3 25
16.9%
Q2 25
9.4%
163.8%
Q1 25
1.6%
3.7%
Q4 24
-114.6%
Q3 24
6.4%
Q2 24
7.4%
8.4%
EPS (diluted)
BLKB
BLKB
HCM
HCM
Q1 26
$0.67
Q4 25
$0.75
$0.00
Q3 25
$0.98
Q2 25
$0.55
$0.52
Q1 25
$0.09
$0.01
Q4 24
$-6.82
Q3 24
$0.35
Q2 24
$0.41
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLKB
BLKB
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$34.1M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$34.6M
$1.2B
Total Assets
$2.1B
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLKB
BLKB
HCM
HCM
Q1 26
$34.1M
Q4 25
$38.9M
$1.4B
Q3 25
$38.3M
Q2 25
$41.6M
$1.4B
Q1 25
$37.2M
$836.1M
Q4 24
$67.6M
Q3 24
$34.6M
Q2 24
$30.4M
$802.5M
Total Debt
BLKB
BLKB
HCM
HCM
Q1 26
Q4 25
$1.1B
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
$1.1B
Q3 24
$1.0B
Q2 24
$1.0B
$82.1M
Stockholders' Equity
BLKB
BLKB
HCM
HCM
Q1 26
$34.6M
Q4 25
$85.1M
$1.2B
Q3 25
$108.2M
Q2 25
$72.7M
$1.2B
Q1 25
$17.5M
$759.9M
Q4 24
$126.8M
Q3 24
$544.8M
Q2 24
$577.5M
$740.1M
Total Assets
BLKB
BLKB
HCM
HCM
Q1 26
$2.1B
Q4 25
$2.4B
$1.8B
Q3 25
$2.1B
Q2 25
$2.6B
$1.8B
Q1 25
$2.1B
$1.3B
Q4 24
$2.5B
Q3 24
$2.6B
Q2 24
$3.0B
$1.3B
Debt / Equity
BLKB
BLKB
HCM
HCM
Q1 26
Q4 25
13.06×
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
8.50×
Q3 24
1.84×
Q2 24
1.78×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLKB
BLKB
HCM
HCM
Operating Cash FlowLast quarter
$51.5M
$8.2M
Free Cash FlowOCF − Capex
$37.0M
$3.4M
FCF MarginFCF / Revenue
13.2%
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
1.65×
4.21×
TTM Free Cash FlowTrailing 4 quarters
$294.1M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLKB
BLKB
HCM
HCM
Q1 26
$51.5M
Q4 25
$58.0M
$8.2M
Q3 25
$139.2M
Q2 25
$66.9M
$-72.9M
Q1 25
$1.4M
$40.3M
Q4 24
$73.6M
Q3 24
$104.0M
Q2 24
$53.1M
$-39.8M
Free Cash Flow
BLKB
BLKB
HCM
HCM
Q1 26
$37.0M
Q4 25
$55.0M
$3.4M
Q3 25
$135.7M
Q2 25
$66.3M
$-82.2M
Q1 25
$712.0K
$32.5M
Q4 24
$73.4M
Q3 24
$102.9M
Q2 24
$48.0M
$-49.9M
FCF Margin
BLKB
BLKB
HCM
HCM
Q1 26
13.2%
Q4 25
18.6%
1.2%
Q3 25
48.3%
Q2 25
23.5%
-29.6%
Q1 25
0.3%
10.0%
Q4 24
24.3%
Q3 24
35.9%
Q2 24
16.7%
-16.3%
Capex Intensity
BLKB
BLKB
HCM
HCM
Q1 26
Q4 25
1.0%
1.8%
Q3 25
1.2%
Q2 25
0.2%
3.3%
Q1 25
0.3%
2.4%
Q4 24
0.1%
Q3 24
0.4%
Q2 24
1.8%
3.3%
Cash Conversion
BLKB
BLKB
HCM
HCM
Q1 26
1.65×
Q4 25
1.58×
4.21×
Q3 25
2.93×
Q2 25
2.53×
-0.16×
Q1 25
0.32×
3.38×
Q4 24
Q3 24
5.69×
Q2 24
2.50×
-1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons